IP Library › Granted Patent US 12,727,792
Granted Patent B2
US 12,727,792 · App. 18/767,060 · Granted Sep 8, 2026

Non-invasive blood glucose monitoring device and manufacturing method thereof

Inventors: Shu-Wen Dai (Hsinchu City, TW); Fu-Yung Tsai (Hsinchu City, TW); Chuan-Fa Lin (Hsinchu City, TW)
Assignee: TAIWAN-ASIA SEMICONDUCTOR CORPORATION
A61B5/14532A61B2562/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,727,792
App. No.
18/767,060
Granted
Sep 8, 2026
Kind
B2
Abstract

The invention provides a manufacturing method for a non-invasive blood glucose monitoring device, which comprises the following steps: providing a substrate; performing an injection molding process or an electroplating process, to form at least one light-blocking wall on the substrate, wherein each light-blocking wall includes a lower wall-structure and an upper wall-structure, and the lower wall-structure connects the substrate and the upper wall-structure connects the lower wall-structure; arranging a light-emitting element and a light-receiving element on the substrate and separating the light-emitting element and the light-receiving element by the at least one light-blocking wall; forming a packaging structure on the substrate in which the light-emitting element and the light-receiving element are packaged; and disposing a transparent cover on the packaging structure and the at least one light-blocking wall and limiting the transparent cover to a configuration height by the at least one light-blocking wall.

Claims (15)

1 . A manufacturing method for a non-invasive blood glucose monitoring device, comprising steps of:

providing a substrate,

performing an injection molding process or an electroplating process, to form at least one light-blocking wall on the substrate, wherein each light-blocking wall includes a lower wall-structure and an upper wall-structure, and the lower wall-structure connects the substrate and the upper wall-structure connects the lower wall-structure,

arranging a light-emitting element and a light-receiving element on the substrate and separating the light-emitting element and the light-receiving element by the at least one light-blocking wall,

forming a packaging structure on the substrate in which the light-emitting element and the light-receiving element are packaged, and

disposing a transparent cover on the packaging structure and the at least one light-blocking wall and limiting the transparent cover to a configuration height by the at least one light-blocking wall,

wherein a width of the lower wall-structure is wider than a width of the upper wall-structure, so that a limit structure for setting the transparent cover is formed by a width difference between the lower wall-structure and the upper wall-structure, and

a height of the upper wall-structure equals a height of the transparent cover.

2 . The manufacturing method for a non-invasive blood glucose monitoring device as claimed in claim 1 , wherein a thermoplastic polymer material is adopted to form the at least one light-blocking wall for the injection molding process.

3 . The manufacturing method for a non-invasive blood glucose monitoring device as claimed in claim 1 , wherein a metal material or an alloy material is adopted to form the at least one light-blocking wall for the electroplating process.

4 . The manufacturing method for a non-invasive blood glucose monitoring device as claimed in claim 1 , wherein the width of the lower wall-structure is two to three times of the width of the upper wall-structure.

5 . The manufacturing method for a non-invasive blood glucose monitoring device as claimed in claim 1 , wherein a width of the lower wall-structure is between 100 μm and 300 μm and a width of the upper wall-structure is between 50 μm and 100 μm.

6 . The manufacturing method for a non-invasive blood glucose monitoring device as claimed in claim 1 , wherein the packaging structure and the lower wall-structure have the same height.

7 . The manufacturing method for a non-invasive blood glucose monitoring device as claimed in claim 1 , wherein each of the light-blocking wall forms a staged and three-dimensional structure through the upper wall-structure and the lower wall-structure.

8 . The manufacturing method for a non-invasive blood glucose monitoring device as claimed in claim 1 , wherein a light transmittance of each of the at least one light-blocking wall is not greater than 5%, or a light reflectance of each of the at least one light-blocking wall is not less than 95%.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2024
From: DAI, SHU-WEN; LIN, CHUAN-FA
To: TAIWAN-ASIA SEMICONDUCTOR CORPORATION
Reel/Frame 068010/0407 →
EMPLOYMENT AGREEMENT Recorded Jul 17, 2024
From: TSAI, FU-YUNG
To: TAIWAN-ASIA SEMICONDUCTOR CORPORATION
Reel/Frame 068187/0646 →
Priority Claims (1)
TW 112139042 · Oct 12, 2023 · national
Continuity (1)
Related Publication 20250120617A1 · Apr 17, 2025
References Cited (14)
US 6952603B2 · Gerber · 2005 [cited by examiner]
US 8764653B2 · Kaminska et al. · 2014 [cited by applicant]
US 11990557B2 · Shen · 2024 [cited by examiner]
US 12230618B2 · Hasegawa · 2025 [cited by examiner]
US 20020161286A1 · Gerber et al. · 2002 [cited by applicant]
US 20150190079A1 · Yamaji · 2015 [cited by examiner]
US 20210282673A1 · Petcavich · 2021 [cited by examiner]
US 20220140173A1 · Shen et al. · 2022 [cited by applicant]
US 20230059535A1 · Tsou et al. · 2023 [cited by applicant]
US 20230062342A1 · Halac et al. · 2023 [cited by applicant]
US 20230301553A1 · Rong et al. · 2023 [cited by applicant]
EP 3892194A1 · 2021 [cited by applicant]
WO 2018223090A1 · 2018 [cited by applicant]
Annotated amendment from EP 24175648, 3 pages. (Year: 2025). [cited by examiner]